NEW YORK (GenomeWeb) - DiagnoCure today reported a 3 percent decrease year over year in its fiscal 2015 first quarter revenues.

For the three months ended Jan. 31, DiagnoCure's total revenues retreated to C$142,915 (US$131,529) from C$146,969 in the year-ago quarter.

Excluding the effects of currency exchange, total revenues decreased by 15 percent to C$112,381 for the first quarter of 2015 compared to C$132,178 in Q1 2014. This decrease is mainly attributable to a 32 percent year over year drop in PCA3 European royalty revenues, the firm said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.